11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

Huerta, R; Dewailly, D; Decanter, C; Knochenhauer, E S; Boots, L R; Azziz, R

Huerta, R; Dewailly, D; Decanter, C; Knochenhauer, E S; Boots, L R; Azziz, R.

Affiliation

Huerta R; Instituto de Investigaciones Medicas, Universidad de Guanajuato, Leon, Mexico.

Fertil Steril ; 72(6): 996-1000, 1999 Dec.

Article in En | MEDLINE | ID: mdl-10593370

Subject(s)

Adrenal Hyperplasia, Congenital/metabolism; Androgens/biosynthesis; Androstenedione/analogs & derivatives; Adult; Androstenedione/blood; Biomarkers/blood; Body Mass Index; Case-Control Studies; Female; Humans; Reproducibility of Results; Sensitivity and Specificity

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adrenal Hyperplasia, Congenital / Androgens / Androstenedione Type of study: Diagnostic_studies / Observational_studies Limits: Adult / Female / Humans Language: En Journal: Fertil Steril Year: 1999 Type: Article Affiliation country: Mexico

Search on Google

XML

PubMed Links